Progress in Molecular Biology and Translational Science, Volume 163: Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics – Part B 1st Edition

by Lijuan Zhang (Editor)

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics – Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases―30 Years Clinical Applications in China, and more.

• Includes comprehensive coverage of molecular biology
• Presents ample use of tables, diagrams, schemata and color figures to enhance the reader’s ability to rapidly grasp the information provided
• Contains contributions from renowned experts in the field